{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:19:55Z","timestamp":1794262795007,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It is necessary to analyze the CT pulmonary vascular parameters and disease severity in chronic obstructive pulmonary disease (COPD) patients to provide evidence support for the management of COPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>COPD patients on acute exacerbation admitted to our hospital from COPD patients from January 2019 to March 2020 was selected. The characteristics and ratio of the cross-sectional area (CSA) of small pulmonary vessels to the total area of the lung field, and the ratio of pulmonary artery and aorta (PA\/A) cross-sectional diameter in patients with COPD were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 128 COPD patients were included. There were significant differences in the duration of COPD, smoking history, the PaO<jats:sub>2<\/jats:sub>, PaCO<jats:sub>2<\/jats:sub>, pH, and FEV1, FVC and FEV1\/FVC among COPD patients with different severity (all p\u2009&lt;\u20090.05). The duration of COPD, smoking, PaO<jats:sub>2<\/jats:sub>, PaCO<jats:sub>2<\/jats:sub>, CSA and PA\/A were correlated with the COPD severity (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Both CSA, PA\/A were correlated with post BD FEV1 (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The cutoff value of CSA and PA\/A for the diagnosis of severe COPD was 0.61 and 0.87 respectively, and the AUC of CSA and PA\/A for the diagnosis of severe COPD was 0.724 and 0.782 respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with CSA\u2009\u2264\u20090.61 and PA\/A\u2009\u2265\u20090.87 may have higher risks for severe COPD, and more studies are needed in the future to further elucidate the management of COPD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-020-01374-6","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T12:03:20Z","timestamp":1611144200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Tao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuanlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"2","key":"1374_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/00325481.2019.1706996","volume":"132","author":"G Hillas","year":"2020","unstructured":"Hillas G, Papaporfyriou A, Dimakou K, Papaioannou AI. Pharmacological treatment of stable COPD: need for a simplified approach. Postgrad Med. 2020;132(2):126\u201331.","journal-title":"Postgrad Med"},{"issue":"2","key":"1374_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/resp.13723","volume":"25","author":"A Agusti","year":"2020","unstructured":"Agusti A. COPD: Challenges and opportunities. Respirology. 2020;25(2):132\u20133.","journal-title":"Respirology"},{"key":"1374_CR3","doi-asserted-by":"publisher","first-page":"104770","DOI":"10.1016\/j.tiv.2020.104770","volume":"65","author":"Y Wu","year":"2020","unstructured":"Wu Y, Guan S, Ge Y, Yang Y, Cao Y, Zhou J. Cigarette smoke promotes chronic obstructive pulmonary disease (COPD) through the miR-130a\/Wnt1 axis. Toxicol In Vitro. 2020;65:104770.","journal-title":"Toxicol In Vitro"},{"issue":"8","key":"1374_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jama.2019.0131","volume":"321","author":"CM Riley","year":"2019","unstructured":"Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786\u201397.","journal-title":"JAMA"},{"issue":"6","key":"1374_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00059-019-4814-7","volume":"44","author":"G Guder","year":"2019","unstructured":"Guder G, Stork S. COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019;44(6):502\u20138.","journal-title":"Herz"},{"issue":"1","key":"1374_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4187\/respcare.01374","volume":"57","author":"GL Ruppel","year":"2012","unstructured":"Ruppel GL, Enright PL. Pulmonary function testing. Respir Care. 2012;57(1):165\u201375.","journal-title":"Respir Care"},{"key":"1374_CR7","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2147\/COPD.S171134","volume":"13","author":"C Crimi","year":"2018","unstructured":"Crimi C, Heffler E, Augelletti T, Campisi R, Noto A, Vancheri C, Crimi N. Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3131\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1374_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.2147\/COPD.S161175","volume":"13","author":"I Skjorten","year":"2018","unstructured":"Skjorten I, Hilde JM, Melsom MN, Hisdal J, Hansteen V, Steine K, Humerfelt S. Exercise capacity in COPD patients with exercise-induced pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2018;13:3599\u2013610.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1374_CR9","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2147\/COPD.S178948","volume":"14","author":"S Marklund","year":"2019","unstructured":"Marklund S, Bui KL, Nyberg A. Measuring and monitoring skeletal muscle function in COPD: current perspectives. Int J Chron Obstruct Pulmon Dis. 2019;14:1825\u201338.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"1374_CR10","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1002\/pri.1820","volume":"25","author":"CL Pereira de Araujo","year":"2020","unstructured":"Pereira de Araujo CL, Pereira Reinaldo G, Foscarini BG, Ferreira Schneider B, Moraes Menezes VJ, Dal Lago P. The effects of pulmonary rehabilitation on endothelial function and arterial stiffness in patients with chronic obstructive pulmonary disease. Physiother Res Int. 2020;25(2):e1820.","journal-title":"Physiother Res Int"},{"issue":"9","key":"1374_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/thoraxjnl-2015-207696","volume":"71","author":"F Coste","year":"2016","unstructured":"Coste F, Dournes G, Dromer C, Blanchard E, Freund-Michel V, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 2016;71(9):830\u20137.","journal-title":"Thorax"},{"issue":"3","key":"1374_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1148\/radiol.2019182143","volume":"292","author":"O Rahman","year":"2019","unstructured":"Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, et al. Reproducibility and changes in vena caval blood flow by using 4D flow MRI in pulmonary emphysema and chronic obstructive pulmonary disease (COPD): the multi-ethnic study of atherosclerosis (MESA) COPD substudy. Radiology. 2019;292(3):585\u201394.","journal-title":"Radiology"},{"key":"1374_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2147\/COPD.S121405","volume":"12","author":"S Takayanagi","year":"2017","unstructured":"Takayanagi S, Kawata N, Tada Y, Ikari J, Matsuura Y, Matsuoka S, Matsushita S, Yanagawa N, Kasahara Y, Tatsumi K. Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? Int J Chron Obstruct Pulmon Dis. 2017;12:551\u201360.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1374_CR14","doi-asserted-by":"crossref","unstructured":"Balkissoon R: Journal Club-COPD2020 Update. Global initiative for chronic obstructive lung disease 2020 report and the journal of the COPD foundation special edition, moving to a new definition for COPD: \"COPDGene((R)) 2019\". Chronic Obstr Pulm Dis. 2019, 6(4).","DOI":"10.15326\/jcopdf.7.1.2020.0133"},{"issue":"18","key":"1374_CR15","first-page":"2141","volume":"27","author":"X Wang","year":"2019","unstructured":"Wang X, Fang X. Global Initiative for Chronic Obstructive Pulmonary Disease 2019: interpretation of the global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease. Chin Gen Pract. 2019;27(18):2141\u20139.","journal-title":"Chin Gen Pract"},{"issue":"1","key":"1374_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12931-018-0734-y","volume":"19","author":"K Ostridge","year":"2018","unstructured":"Ostridge K, Williams NP, Kim V, Harden S, Bourne S, Clarke SC, Aris E, Mesia-Vela S, Devaster JM, Tuck A, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31.","journal-title":"Respir Res"},{"issue":"6980","key":"1374_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/bmj.310.6980.616","volume":"310","author":"S Worthy","year":"1995","unstructured":"Worthy S. High resolution computed tomography of the lungs. BMJ. 1995;310(6980):615\u20136.","journal-title":"BMJ"},{"issue":"7","key":"1374_CR18","first-page":"502","volume":"12","author":"Y Liao","year":"2018","unstructured":"Liao Y, Wang X, Bai Y. The clinical significance of high-resolution CT pulmonary vascular indexes in evaluating pulmonary hypertension in patients with COPD. Int J Respir. 2018;12(7):502\u20139.","journal-title":"Int J Respir"},{"issue":"7","key":"1374_CR19","first-page":"515","volume":"39","author":"C Wang","year":"2019","unstructured":"Wang C, Xu J, Wu Z. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir. 2019;39(7):515\u201320.","journal-title":"Int J Respir"},{"issue":"2","key":"1374_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MCP.0000000000000649","volume":"26","author":"AN Venkata","year":"2020","unstructured":"Venkata AN. Asthma-COPD overlap: review of diagnosis and management. Curr Opin Pulm Med. 2020;26(2):155\u201361.","journal-title":"Curr Opin Pulm Med"},{"key":"1374_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/COPD.S234942","volume":"15","author":"I Iheanacho","year":"2020","unstructured":"Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439\u201360.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1374_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2019.12.032","volume":"73","author":"LE Vanfleteren","year":"2020","unstructured":"Vanfleteren LE, Beghe B, Andersson A, Hansson D, Fabbri LM, Grote L. Multimorbidity in COPD, does sleep matter? Eur J Intern Med. 2020;73:7\u201315.","journal-title":"Eur J Intern Med"},{"key":"1374_CR23","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.rmed.2020.105938","volume":"166","author":"CF Vogelmeier","year":"2020","unstructured":"Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir Med. 2020;166:105938.","journal-title":"Respir Med"},{"issue":"7","key":"1374_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1042\/CS20180316","volume":"133","author":"K Brassington","year":"2019","unstructured":"Brassington K, Selemidis S, Bozinovski S, Vlahos R. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease. Clin Sci (Lond). 2019;133(7):885\u2013904.","journal-title":"Clin Sci (Lond)"},{"key":"1374_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1900\/RDS.2019.15.1","volume":"15","author":"J Khateeb","year":"2019","unstructured":"Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: a neglected relationship. Rev Diabet Stud. 2019;15:1\u201315.","journal-title":"Rev Diabet Stud"},{"key":"1374_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.rmed.2019.08.003","volume":"156","author":"AP Laddha","year":"2019","unstructured":"Laddha AP, Kulkarni YA. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders. Respir Med. 2019;156:33\u201346.","journal-title":"Respir Med"},{"key":"1374_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/COPD.S177638","volume":"14","author":"F Coste","year":"2019","unstructured":"Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, et al. Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2019;14:381\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1374_CR28","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2147\/COPD.S107424","volume":"11","author":"K Yoshimura","year":"2016","unstructured":"Yoshimura K, Suzuki Y, Uto T, Sato J, Imokawa S, Suda T. Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:1435\u201345.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"1374_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/cpf.12215","volume":"36","author":"S Saruya","year":"2016","unstructured":"Saruya S, Matsuoka S, Yamashiro T, Matsushita S, Fujikawa A, Yagihashi K, Kurihara Y, Nakajima Y. Quantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans? Clin Physiol Funct Imaging. 2016;36(3):211\u20137.","journal-title":"Clin Physiol Funct Imaging"},{"issue":"11","key":"1374_CR30","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.ejrad.2016.09.010","volume":"85","author":"A Nambu","year":"2016","unstructured":"Nambu A, Zach J, Schroeder J, Jin G, Kim SS, Kim YI, Schnell C, Bowler R, Lynch DA. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144\u201351.","journal-title":"Eur J Radiol"},{"key":"1374_CR31","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2147\/COPD.S207363","volume":"14","author":"F Coste","year":"2019","unstructured":"Coste F, Benlala I, Dournes G, Girodet PO, Laurent F, Berger P. Assessing pulmonary hypertension in COPD. Is there a role for computed tomography? Int J Chron Obstruct Pulmon Dis. 2019;14:2065\u201379.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"1374_CR32","doi-asserted-by":"publisher","first-page":"e0198479","DOI":"10.1371\/journal.pone.0198479","volume":"13","author":"K Yoshimura","year":"2018","unstructured":"Yoshimura K, Suzuki Y, Inoue Y, Nishimoto K, Mori K, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, et al. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. PLoS ONE. 2018;13(6):e0198479.","journal-title":"PLoS ONE"},{"issue":"2","key":"1374_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/2045893217709001","volume":"7","author":"EM Faight","year":"2017","unstructured":"Faight EM, Verdelis K, Zourelias L, Chong R, Benza RL, Shields KJ. MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN\/hypoxic rat model of pulmonary arterial hypertension. Pulm Circ. 2017;7(2):522\u201330.","journal-title":"Pulm Circ"},{"issue":"1","key":"1374_CR34","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1152\/ajpregu.00165.2017","volume":"315","author":"JV Brugniaux","year":"2018","unstructured":"Brugniaux JV, Coombs GB, Barak OF, Dujic Z, Sekhon MS, Ainslie PN. Highs and lows of hyperoxia: physiological, performance, and clinical aspects. Am J Physiol Regul Integr Comp Physiol. 2018;315(1):R1\u201327.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"1374_CR35","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","volume":"198","author":"G Kovacs","year":"2018","unstructured":"Kovacs G, Agusti A, Barbera JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype? Am J Respir Crit Care Med. 2018;198(8):1000\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1374_CR36","first-page":"515","volume":"39","author":"C Wang","year":"2019","unstructured":"Wang C, Xu J, Wu Z, Cheng M. Correlation between CT pulmonary vascular parameters and severity of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Respir Med. 2019;39(7):515\u201320.","journal-title":"Int J Respir Med"},{"issue":"4","key":"1374_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1183\/13993003.00745-2017","volume":"51","author":"A Huertas","year":"2018","unstructured":"Huertas A, Guignabert C, Barbera JA, Bartsch P, Bhattacharya J, Bhattacharya S, Bonsignore MR, Dewachter L, Dinh-Xuan AT, Dorfmuller P, et al. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy. Eur Respir J. 2018;51(4):10.","journal-title":"Eur Respir J"},{"issue":"6","key":"1374_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/aos.13765","volume":"96","author":"AW Vaes","year":"2018","unstructured":"Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P. Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients. Acta Ophthalmol. 2018;96(6):539\u201349.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"1374_CR39","doi-asserted-by":"publisher","first-page":"L743","DOI":"10.1152\/ajplung.00373.2017","volume":"314","author":"Q Lu","year":"2018","unstructured":"Lu Q, Gottlieb E, Rounds S. Effects of cigarette smoke on pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2018;314(5):L743\u201356.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"1374_CR40","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s10067-019-04673-4","volume":"38","author":"L Li","year":"2019","unstructured":"Li L, Gao S, Fu Q, Liu R, Zhang Y, Dong X, Li Y, Li M, Zheng Y. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis. Clin Rheumatol. 2019;38(11):3169\u201378.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1374_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12931-017-0578-x","volume":"18","author":"M Kolodziej","year":"2017","unstructured":"Kolodziej M, de Veer MJ, Cholewa M, Egan GF, Thompson BR. Lung function imaging methods in Cystic Fibrosis pulmonary disease. Respir Res. 2017;18(1):96.","journal-title":"Respir Res"},{"issue":"2","key":"1374_CR42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/art.41085","volume":"72","author":"GHJ Kim","year":"2020","unstructured":"Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, et al. Using transitional changes on high-resolution computed tomography to monitor the impact of cyclophosphamide or Mycophenolate mofetil on systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol. 2020;72(2):316\u201325.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1374_CR43","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/diagnostics10040244","volume":"10","author":"G Distefano","year":"2020","unstructured":"Distefano G, Fanzone L, Palermo M, Tiralongo F, Cosentino S, Ini C, Galioto F, Vancheri A, Torrisi SE, Mauro LA, et al. HRCT patterns of drug-induced interstitial lung diseases: a review. Diagnostics (Basel). 2020;10(4):244.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"1374_CR44","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10067-020-04938-3","volume":"39","author":"AM Ferrazza","year":"2020","unstructured":"Ferrazza AM, Gigante A, Gasperini ML, Ammendola RM, Paone G, Carbone I, Rosato E. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER. Clin Rheumatol. 2020;39(5):1537\u201342.","journal-title":"Clin Rheumatol"},{"key":"1374_CR45","doi-asserted-by":"publisher","first-page":"e923885","DOI":"10.12659\/MSM.923885","volume":"26","author":"L Gao","year":"2020","unstructured":"Gao L, Zhang J. Pulmonary high-resolution computed tomography (HRCT) findings of patients with early-stage coronavirus disease 2019 (COVID-19) in Hangzhou, China. Med Sci Monit. 2020;26:e923885.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1374_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2214\/AJR.19.21585","volume":"214","author":"X Shao","year":"2020","unstructured":"Shao X, Niu R, Jiang Z, Shao X, Wang Y. Role of PET\/CT in management of early lung adenocarcinoma. AJR Am J Roentgenol. 2020;214(2):437\u201345.","journal-title":"AJR Am J Roentgenol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01374-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:05:20Z","timestamp":1674900320000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01374-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01374-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"16 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was a retrospective analysis. This present study had been verified and approved by the ethics committee of Chest Hospital of Xinjiang Uygur Autonomous region of the PRC (approval number: 20190112-3a), and written informed consents had been obtained from all the included patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}